{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T23:31:24Z","timestamp":1694129484052},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T00:00:00Z","timestamp":1382486400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00280-013-2314-7","type":"journal-article","created":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T06:37:09Z","timestamp":1382423829000},"page":"35-42","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of the QTc prolongation potential of a monoclonal antibody, siltuximab, in patients with monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or low-volume multiple myeloma"],"prefix":"10.1007","volume":"73","author":[{"given":"Sheeba K.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Suvorov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucien","family":"Noens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg","family":"Rukavitsin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Fay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ka Lung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd M.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helgi","family":"van de Velde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Bandekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Puchalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarissa","family":"Uhlar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga S.","family":"Samoylova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,23]]},"reference":[{"issue":"1","key":"2314_CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A (2013) Cancer statistics. CA Cancer J Clin 63(1):11\u201330. doi: 10.3322\/caac.21166","journal-title":"CA Cancer J Clin"},{"issue":"22","key":"2314_CR2","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, Dispenzieri A, Kumar S, Clark RJ, Baris D, Hoover R, Rajkumar SV (2009) Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 113(22):5412\u20135417. doi: 10.1182\/blood-2008-12-194241","journal-title":"Blood"},{"issue":"25","key":"2314_CR3","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMoa070389","volume":"356","author":"RA Kyle","year":"2007","unstructured":"Kyle RA, Remstein ED, Therneau TM, Dispenzieri A, Kurtin PJ, Hodnefield JM, Larson DR, Plevak MF, Jelinek DF, Fonseca R, Melton LJ 3rd, Rajkumar SV (2007) Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med 356(25):2582\u20132590. doi: 10.1056\/NEJMoa070389","journal-title":"N Engl J Med"},{"issue":"6","key":"2314_CR4","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","volume":"24","author":"RA Kyle","year":"2010","unstructured":"Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, Kroger N, Einsele H, Vesole DH, Dimopoulos M, San Miguel J, Avet-Loiseau H, Hajek R, Chen WM, Anderson KC, Ludwig H, Sonneveld P, Pavlovsky S, Palumbo A, Richardson PG, Barlogie B, Greipp P, Vescio R, Turesson I, Westin J, Boccadoro M (2010) Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 24(6):1121\u20131127. doi: 10.1038\/leu.2010.60","journal-title":"Leukemia"},{"issue":"1","key":"2314_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/leu.2008.291","volume":"23","author":"RA Kyle","year":"2009","unstructured":"Kyle RA, Rajkumar SV (2009) Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia 23(1):3\u20139. doi: 10.1038\/leu.2008.291","journal-title":"Leukemia"},{"key":"2314_CR6","doi-asserted-by":"crossref","unstructured":"Mateos MV, Lopez-Corralo L, Hernadez M, Giraldo P, De La Rubia J, de Arriba F, Rosinol L, Lahuerta JJ, Palomera L, Bargary J, Oriol A, Prosper F, Lopez J, Olavarria E, Martino ML, Teruel A, Hernandex JM (2011) Smoldering multiple myeloma (SMM) at high-risk of progression to symptomatic disease: a phase III, randomized, multicenter trial based on lenalidomide\u2013dexamethasone (Len\u2013Dex) as induction therapy followed by maintenance therapy with len alone vs no treatment. Blood 118 (ASH Annual meeting abstracts): abstract 991","DOI":"10.1182\/blood.V118.21.991.991"},{"issue":"2","key":"2314_CR7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4065\/84.2.114","volume":"84","author":"JA Lust","year":"2009","unstructured":"Lust JA, Lacy MQ, Zeldenrust SR, Dispenzieri A, Gertz MA, Witzig TE, Kumar S, Hayman SR, Russell SJ, Buadi FK, Geyer SM, Campbell ME, Kyle RA, Rajkumar SV, Greipp PR, Kline MP, Xiong Y, Moon-Tasson LL, Donovan KA (2009) Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component. Mayo Clin Proc 84(2):114\u2013122. doi: 10.4065\/84.2.114","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"2314_CR8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1084\/jem.182.1.243","volume":"182","author":"DM Hilbert","year":"1995","unstructured":"Hilbert DM, Kopf M, Mock BA, Kohler G, Rudikoff S (1995) Interleukin 6 is essential for in vivo development of B lineage neoplasms. J Exp Med 182(1):243\u2013248","journal-title":"J Exp Med"},{"issue":"2","key":"2314_CR9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0022-1759(02)00168-0","volume":"267","author":"J Seideman","year":"2002","unstructured":"Seideman J, Peritt D (2002) A novel monoclonal antibody screening method using the Luminex-100 microsphere system. J Immunol Methods 267(2):165\u2013171","journal-title":"J Immunol Methods"},{"key":"2314_CR10","doi-asserted-by":"crossref","unstructured":"Kurzrock R, Voorhees PM, Casper C, Furman RR, Fayad L, Lonial S, Borghaei H, Jagannath S, Sokol L, Usmani SZ, van de Velde H, Qin X, Puchalski TA, Hall B, Reddy M, Qi M, van Rhee F (2013) A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma, multiple myeloma, or Castleman disease. Clin Cancer Res 19(13):3659\u20133670. doi: 10.1158\/1078-0432.CCR-12-3349","DOI":"10.1158\/1078-0432.CCR-12-3349"},{"issue":"23","key":"2314_CR11","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1200\/JCO.2009.27.2377","volume":"28","author":"F Rhee van","year":"2010","unstructured":"van Rhee F, Fayad L, Voorhees P, Furman R, Lonial S, Borghaei H, Sokol L, Crawford J, Cornfeld M, Qi M, Qin X, Herring J, Casper C, Kurzrock R (2010) Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman\u2019s disease. J Clin Oncol 28(23):3701\u20133708. doi: 10.1200\/JCO.2009.27.2377","journal-title":"J Clin Oncol"},{"issue":"8","key":"2314_CR12","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/sj.bjc.6605872","volume":"103","author":"JF Rossi","year":"2010","unstructured":"Rossi JF, Negrier S, James ND, Kocak I, Hawkins R, Davis H, Prabhakar U, Qin X, Mulders P, Berns B (2010) A phase I\/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer. Br J Cancer 103(8):1154\u20131162. doi: 10.1038\/sj.bjc.6605872","journal-title":"Br J Cancer"},{"issue":"15 Suppl","key":"2314_CR13","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1200\/jco.2012.30.15_suppl.2583","volume":"30","author":"E Angevin","year":"2012","unstructured":"Angevin E, Elez E, Cohen SJ, van laethem J-L, Ottensmeier C, Joly F, Ray-Coquard I, Lopez-Martin JA, Dirix L, Machiels J-P, Clive S, Steven NM, Reddy M, Hall B, Puchalski TA, Bandekar R, Van de Velde H, Tromp BJ, Vermeulen J, Kurzrock R (2012) Phase I\/II, two-part, open-label, multiple-dose, dose-escalation study of siltuximab in patients with solid tumors. J Clin Oncol 30(15 Suppl):2583","journal-title":"J Clin Oncol"},{"issue":"Suppl 10","key":"2314_CR14","first-page":"1614","volume":"60","author":"S Grange","year":"2009","unstructured":"Grange S, Schmitt C, Gerogy A, Ludger B, Kuhn B, Zhang X (2009) A clinical study to assess the effect of tocilizumab at a therapeutic dose and a supra-therapeutic dose of tocilizumab on QT\/QTc interval after a single dose in healthy subjects. Arthritis Rheum 60(Suppl 10):1614. doi: 10.1002\/art.26688","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2314_CR15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11864-000-0056-3","volume":"1","author":"PR Greipp","year":"2000","unstructured":"Greipp PR (2000) Smoldering, asymptomatic stage 1, and indolent myeloma. Curr Treat Options Oncol 1(2):119\u2013126","journal-title":"Curr Treat Options Oncol"},{"issue":"5","key":"2314_CR16","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1158\/1078-0432.CCR-09-2581","volume":"16","author":"T Puchalski","year":"2010","unstructured":"Puchalski T, Prabhakar U, Jiao Q, Berns B, Davis HM (2010) Pharmacokinetic and pharmacodynamic modeling of an anti-interleukin-6 chimeric monoclonal antibody (siltuximab) in patients with metastatic renal cell carcinoma. Clin Cancer Res 16(5):1652\u20131661. doi: 10.1158\/1078-0432.CCR-09-2581","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2314_CR17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.0954-6820.1920.tb18266.x","volume":"53","author":"LS Fridericia","year":"1920","unstructured":"Fridericia LS (1920) Die systolendauer im elektrokardiogramm bei normalen menschen und bei herzkranken. Acta Med Scand 53(1):469\u2013486","journal-title":"Acta Med Scand"},{"key":"2314_CR18","first-page":"353","volume":"70","author":"HC Bazett","year":"1919","unstructured":"Bazett HC (1919) An analysis of the time-relationship of electrocardiograms. Heart 70:353\u2013370","journal-title":"Heart"},{"key":"2314_CR19","unstructured":"International Conference on Harmonisation (2005) guidance on E14 clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs; availability. Notice. Fed Regist 70(202):61134\u201361135"},{"issue":"3","key":"2314_CR20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bjh.12266","volume":"161","author":"PM Voorhees","year":"2013","unstructured":"Voorhees PM, Manges RF, Sonneveld P, Jagannath S, Somlo G, Krishnan A, Lentzsch S, Frank RC, Zweegman S, Wijermans PW, Orlowski RZ, Kranenburg B, Hall B, Casneuf T, Qin X, van de Velde H, Xie H, Thomas SK (2013) A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma. Br J Haematol 161(3):357\u2013366. doi: 10.1111\/bjh.12266","journal-title":"Br J Haematol"},{"issue":"25","key":"2314_CR21","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1182\/blood-2012-03-417253","volume":"120","author":"BM Birmann","year":"2012","unstructured":"Birmann BM, Neuhouser ML, Rosner B, Albanes D, Buring JE, Giles GG, Lan Q, Lee IM, Purdue MP, Rothman N, Severi G, Yuan JM, Anderson KC, Pollak M, Rifai N, Hartge P, Landgren O, Lessin L, Virtamo J, Wallace RB, Manson JE, Colditz GA (2012) Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium. Blood 120(25):4929\u20134937. doi: 10.1182\/blood-2012-03-417253","journal-title":"Blood"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-013-2314-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-013-2314-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-013-2314-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T09:07:17Z","timestamp":1596704837000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-013-2314-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,23]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["2314"],"URL":"https:\/\/doi.org\/10.1007\/s00280-013-2314-7","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,23]]}}}